UCB has been undergoing a far-reaching digital business transformation, integrating novel approaches across its R&D organisation, including…

Digitalisation has become a buzz word in in the global life sciences sector. In Italy, digital transformation has taken on special significance as one…

UCB Italy's Managing Director, Federico Chinni offeres his insights into UCB's positioning and its new product launches, the first for the company in…

UCB’s general manager for Iberia, Pau Ricós, comments on the Belgian company’s upcoming launches, its focus on immunology and neurology, and the…

Belgian champion UCB's global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufacturing and supply chain…

UCB’s Omar Lugo Aguirre outlines the company’s response to the COVID-19 pandemic in Mexico, countering stigmas around neurodegenerative and mental…

After reaching revenues of EUR 2.323 billion in the first six months of 2019, UCB announced on December 18 that it will build an innovative…

Jean-Christophe Tellier became UCB’s CEO on January 1, 2015 only a few years joining the company in 2011. Before taking on the role Tellier held…

Jesús Sobrino, area head of UCB Iberia, and global leader for UCB's Patients Experience Program, discusses the significance of the affiliate, which…

Newly-appointed general manager of UCB France, Catherine Rives, discusses what drew her back to the company after time away, market access issues in…

Albin Egger, country representative of UCB Pharma Austria, discusses the strong performance of the Austrian affiliate within the global group,…

Nicolas Hug reveals how UCB´s new facility in Bulle, Switzerland, is one of the largest microbial derived pharmaceuticals plants in Europe; how the…